TORONTO, July 27, 2018 /CNW/ - Pure Global Cannabis Inc. (TSXV: PURE) (OTC: PRCNF) (the "Company" or "PURE") is pleased to announce that its wholly-owned subsidiary, PureSinse Inc. ("PureSinse") has signed definitive Supply Agreements with The Supreme Cannabis Company, Inc. ("Supreme") (TSXV: FIRE) and two other reputable Access to Cannabis for Medical Purposes Regulations ("ACMPR") Licensed Producers, from whom PureSinse has purchased various quantities of premium quality medical cannabis that meet the high-quality standard requirements of PURE.
These Agreements represent a significant milestone for PureSinse, as it has now received the necessary product required to obtain a Sales License under the ACMPR which is expected in Q3 2018.
Pure Global President & CEO Malay Panchal stated: "Procuring adequate supply of quality cannabis is an important milestone for PURE as we approach our full market launch for serving medical cannabis patients across Canada within the next several months." "We will continue to work with Supreme and several other premium quality ACMPR producers to execute Phase I of our business model to initiate revenue generation as soon as possible," Panchal added.
About Pure Global Cannabis
Pure Global Cannabis Inc. (TSXV: PURE) (OTC: PRCNF) is a vertically integrated growth-oriented life sciences cannabis company led by experienced pharma-industry, horticultural, and supply chain experts. The Company's wholly-owned subsidiary, PureSinse, is a licensed producer under the Access to Cannabis for Medical Purposes Regulations ("ACMPR") focused on producing premium-quality cannabis products for medical, wellness, and future legal adult recreational use. The Company is launching Canada's first multi-ponic cannabis farm – a patent-pending system that is expected to produce several fold greater yields over traditional methods while reducing cost and eliminating pesticide and herbicide use.
About Supreme Cannabis
The Supreme Cannabis Company Inc. (TSXV: FIRE) is a Canadian publicly traded company committed to providing premium brands and products that proudly reflect its consumers, people and uniquely innovative culture. The Company's portfolio includes its wholly-owned subsidiary and flagship brand 7ACRES.
7ACRES is a federally licensed producer of medical cannabis operating inside a 342,000-square-foot facility in Kincardine, Ontario. 7ACRES is dedicated to providing consumers with a premium-quality product that recognizes its customers are informed, discerning and value a brand and culture that aligns with their principles. 7ACRES brand success has been reflected in provincial supply agreements, where 7ACRES' product is consistently listed in the highest brand category available to recreational consumers.
This news release contains certain forward-looking statements, including, but not limited to, statements about Pure Global's future plans and intentions. Wherever possible, words such as "may", "will", "should", "could", "expect", "plan", "intend", "anticipate", "believe", "estimate", "predict" or "potential" or the negative or other variations of these words, or similar words or phrases, have been used to identify these forward-looking statements. These statements reflect management's current beliefs and are based on information currently available to management as at the date hereof.
Forward-looking statements involve significant risk, uncertainties and assumptions. Many factors could cause actual results, performance or achievements to differ materially from the results discussed or implied in the forward-looking statements. These factors should be considered carefully and readers should not place undue reliance on the forward-looking statements. Although the forward-looking statements contained in this news release are based upon what management believes to be reasonable assumptions, Pure Global cannot assure readers that actual results will be consistent with these forward-looking statements. These forward-looking statements are made as of the date of this news release, and Pure Global assumes no obligation to update or revise them to reflect new events or circumstances, except as required by law.
Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.
SOURCE Pure Global Cannabis Inc.
For further information: regarding Pure Global, please contact: Stephen Pynn, VP Corporate Development, Telephone: 1-866-899-PURE (7873), E-mail: firstname.lastname@example.org; Malay (Mel) Panchal, President & CEO, Telephone: 1-866-899-PURE (7873), E-mail: email@example.com